ReviewFrontiers in immunology2021

Endogenous Fructose Metabolism Could Explain the Warburg Effect and the Protection of SGLT2 Inhibitors in Chronic Kidney Disease.

Takahiko Nakagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.